S 551 116th Congress Senate

REFUND Act of 2019

Official title: A bill to amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program … Show full official titleShow less

Official title: A bill to amend title XVIII of the Social Security Act to require manufacturers of certain single-dose vial drugs payable under part B of the Medicare program to provide rebates with respect to amounts of such drugs discarded, and for other purposes.

Introduced: May 23, 2019 Introduced by: Durbin, Richard J. Democratic · Illinois See on congress.gov

Health Accounting and auditingCivil actions and liabilityGovernment trust fundsHealth care costs and insurance

More subjectsShow fewer subjects

Health information and medical recordsInflation and pricesMedicarePrescription drugs

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 25, 2019

Read twice and referred to the Committee on Finance. (text: CR S1439)

Feb 25, 2019

Introduced in Senate

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action February 25, 2019

Read twice and referred to the Committee on Finance. (text: CR S1439)

Plain-English summary Congressional Research Service

Recovering Excessive Funds for Unused and Needless Drugs Act of 2019 or the REFUND Act of 2019

This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) in relation to discarded amounts (i.e., amounts remaining after administration) of single-dose vial drugs that are covered under Medicare. Manufacturers that fail to comply are subject to civil penalties.

The CMS must determine rebate amounts based on payment claims from providers. (Currently, providers may receive payment under Medicare for discarded amounts of single-dose vial drugs through the use of a specific claims modifier.)

Related & companion bills 1

Bill text 1 version